Transcriptional regulators play pivotal roles in many physiological and pathological processes such as cell proliferation and differentiation, as well as oncogenic transformation. A main interest of my lab is to understand the biology and mechanism of action of Yin Yang 1 (YY1), a C2H2-type zinc finger transcription factor that can both repress and activate transcription. YY1 has been implicated in cell growth and transformation, but such a function has not been demonstrated experimentally, and thus the cellular function of YY1 has remained speculative. In the past funding period, we have made the exciting discovery that YY1 plays an essential role in p53 homeostasis, which impacts on cell growth and apoptosis. At least part of this regulation appears to be independent of YY1 transcriptional role, thus uncovering a novel, non-transcription-based mechanism by which YY1 regulates cell physiology in vivo. These findings have filled an important gap in our understanding of YY1 and also have significant implications for p53 regulation in vivo. A main focus of this application is to understand the mechanisms by which YY1 regulates p53 stability, which is controlled primarily by Mdm2-mediated ubiquitination and proteasome degradation. We will test several mutually non-exclusive models, including YY1 regulation of mdm2-p53 via physical interactions, YY1 cooperation with Mdm2 to stimulate p53 ubiquitination, as well as the possibility of YY1 regulation of deubiquitinases (Aims 1 and 2). Multiple lines of evidence, including the YY1-p53 connection, predict a function for YY1 in cell proliferation and oncogenic transformation, which will be investigated using the YY1-deficient MEF cells that we have developed recently (Aim 3). These cells also make it possible to identify, at the genome-wide level, YY1 target genes in vivo (microarray) (Aim 4). Knowledge of bona fide YY1 target genes is likely to shed light on potential molecular basis of YY1 functions, and will allow us to test, at the genome-wide level, the hypothesis that YY1 activates and represses transcription by inducing differential histone modifications (Aim 4). Taken together, the proposed studies will not only provide molecular insights into YY1 but also shed light on general mechanisms that control p53 homeostasis, cell proliferation, oncogenic transformation and differentiation.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM053874-13
Application #
6839968
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Anderson, Richard A
Project Start
1993-02-10
Project End
2008-01-31
Budget Start
2005-02-01
Budget End
2006-01-31
Support Year
13
Fiscal Year
2005
Total Cost
$457,747
Indirect Cost
Name
Harvard University
Department
Pathology
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Pan, Xuan; Papasani, Madhusudhan; Hao, Yi et al. (2013) YY1 controls Ig? repertoire and B-cell development, and localizes with condensin on the Ig? locus. EMBO J 32:1168-82
Yu, Helen; Mashtalir, Nazar; Daou, Salima et al. (2010) The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression. Mol Cell Biol 30:5071-85
Wu, Su; Hu, Yueh-Chiang; Liu, Huifei et al. (2009) Loss of YY1 impacts the heterochromatic state and meiotic double-strand breaks during mouse spermatogenesis. Mol Cell Biol 29:6245-56
Qi, Hank H; Ongusaha, Pat P; Myllyharju, Johanna et al. (2008) Prolyl 4-hydroxylation regulates Argonaute 2 stability. Nature 455:421-4
Wu, Su; Shi, Yujiang; Mulligan, Peter et al. (2007) A YY1-INO80 complex regulates genomic stability through homologous recombination-based repair. Nat Struct Mol Biol 14:1165-72
Chen, Jing; Wall, Nathan R; Kocher, Kerry et al. (2004) Stable expression of small interfering RNA sensitizes TEL-PDGFbetaR to inhibition with imatinib or rapamycin. J Clin Invest 113:1784-91
Sui, Guangchao; Affar, El Bachir; Shi, Yujiang et al. (2004) Yin Yang 1 is a negative regulator of p53. Cell 117:859-72
Lin, Xia; Liang, Yao-Yun; Sun, Baohua et al. (2003) Smad6 recruits transcription corepressor CtBP to repress bone morphogenetic protein-induced transcription. Mol Cell Biol 23:9081-93
Wall, Nathan R; Shi, Yang (2003) Small RNA: can RNA interference be exploited for therapy? Lancet 362:1401-3
Lee, J S; Zhang, X; Shi, Y (1996) Differential interactions of the CREB/ATF family of transcription factors with p300 and adenovirus E1A. J Biol Chem 271:17666-74